Alpha-neoagarobiose hydrolase and method for obtaining a monosaccharide using same
US-9297000-B2 · Mar 29, 2016 · US
Method for preparing 3,6-anhydro-L-galactose, and use thereof
US10071041B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10071041-B2 |
| Application number | US-201715689840-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 29, 2017 |
| Priority date | Jan 18, 2012 |
| Publication date | Sep 11, 2018 |
| Grant date | Sep 11, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to a method for preparing 3,6-anhydro-L-galactose, and use thereof. More specifically, 3,6-anhydro-L-galactose, which is a monosaccharide constituting agar, is produced in a high yield through chemical and enzymatic methods, and the physiological activities thereof such as whitening, moisturizing, antioxidant, anti-inflammatory activities and the like are displayed, thereby enabling industrial use thereof.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of whitening a skin, comprising administering an effective amount of 3,6-anhydro-L-galactose to a subject in need thereof. 2. The method of claim 1 , wherein said administering includes applying 3,6-anhydro-L-galactose onto the skin.
Assignees
Inventors
Classifications
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1) · CPC title
Monosaccharides having only carbon, hydrogen and oxygen atoms · CPC title
Drugs for dermatological disorders · CPC title
Anhydrosugars, e.g. epoxides · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10071041B2 cover?
- The present invention relates to a method for preparing 3,6-anhydro-L-galactose, and use thereof. More specifically, 3,6-anhydro-L-galactose, which is a monosaccharide constituting agar, is produced in a high yield through chemical and enzymatic methods, and the physiological activities thereof such as whitening, moisturizing, antioxidant, anti-inflammatory activities and the like are displayed…
- Who is the assignee on this patent?
- Univ Korea Res & Bus Found
- What technology area does this patent fall under?
- Primary CPC classification A61K8/60. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).